(Q36131774)

12 August 2017

0 references

Complete response after short-term sorafenib treatment in a patient with lymph node metastasis of hepatocellular carcinoma (English)

1 reference

12 August 2017

lymph node metastasis

1 reference

Hajime Mizukami

1

1 reference

12 August 2017

Tatehiro Kagawa

2

1 reference

12 August 2017

Yoshitaka Arase

3

1 reference

12 August 2017

Fumio Nakahara

4

1 reference

12 August 2017

Kota Tsuruya

5

1 reference

12 August 2017

Kazuya Anzai

6

1 reference

12 August 2017

Shunji Hirose

7

1 reference

12 August 2017

Koichi Shiraishi

8

1 reference

12 August 2017

Masako Shomura

9

1 reference

12 August 2017

Jun Koizumi

10

1 reference

12 August 2017

Kosuke Tobita

11

1 reference

12 August 2017

Tetsuya Mine

12

1 reference

12 August 2017

1 May 2012

1 reference

12 August 2017

Case reports in oncology

1 reference

12 August 2017

5

1 reference

12 August 2017

2

1 reference

12 August 2017

380-384

1 reference

Complete response for advanced liver cancer during sorafenib therapy: case report

12 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3409511

Positioning of a molecular-targeted agent, sorafenib, in the treatment algorithm for hepatocellular carcinoma and implication of many complete remission cases in Japan

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3409511

Efficacy and safety of sorafenib in patients in the Asia-Pacific region with advanced hepatocellular carcinoma: a phase III randomised, double-blind, placebo-controlled trial

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3409511

Sorafenib in advanced hepatocellular carcinoma

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3409511

New guidelines to evaluate the response to treatment in solid tumors. European Organization for Research and Treatment of Cancer, National Cancer Institute of the United States, National Cancer Institute of Canada

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3409511

Apparent remission of a solitary metastatic pulmonary lesion in a liver transplant recipient treated with sorafenib

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3409511

Complete response of advanced hepatocellular carcinoma with multiple lung metastases treated with sorafenib: a case report.

2 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3409511

Complete regression of locally advanced hepatocellular carcinoma induced by sorafenib allowing curative resection.

23 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3409511

Rapid regression of advanced hepatocellular carcinoma associated with elevation of des-gamma-carboxy prothrombin after short-term treatment with sorafenib - a report of two cases

23 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3409511

Complete histologic response induced by sorafenib in advanced hepatocellular carcinoma: a case report.

23 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3409511

Complete remission of unresectable hepatocellular carcinoma treated with reduced dose of sorafenib: a case report

23 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3409511

Complete clinical response of metastatic hepatocellular carcinoma to sorafenib in a patient with hemochromatosis: a case report

23 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3409511

Relation of interferon therapy and hepatocellular carcinoma in patients with chronic hepatitis C. Osaka Hepatocellular Carcinoma Prevention Study Group

23 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3409511

Complete response after sorafenib therapy for hepatocellular carcinoma in an HIV-HBV co infected patient: Possible synergy with HAART ? A case report

23 September 2018

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/23525021

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Identifiers

DOI

10.1159/000341259

1 reference

release_7mv2tdzn3vd77f5xwvgqzunfry

12 August 2017

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/7mv2tdzn3vd77f5xwvgqzunfry

mapped directly with Wikidata item

24 November 2022

based on heuristic

1 reference

12 August 2017

PubMed publication ID

23525021

1 reference